NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 84 filers reported holding NEOGENOMICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $293,846 | +88.4% | 16,878 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $155,953 | +10.6% | 16,878 | +3.0% | 0.00% | 0.0% |
| Q3 2022 | $141,000 | +6.0% | 16,379 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $133,000 | -33.2% | 16,379 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $199,000 | -64.4% | 16,379 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $559,000 | -49.4% | 16,379 | -28.5% | 0.00% | -50.0% |
| Q3 2021 | $1,105,000 | +6.8% | 22,911 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,035,000 | -23.3% | 22,911 | -18.1% | 0.01% | -25.0% |
| Q1 2021 | $1,349,000 | -43.7% | 27,967 | -37.1% | 0.01% | -42.9% |
| Q4 2020 | $2,395,000 | +29.6% | 44,492 | -11.2% | 0.01% | +16.7% |
| Q3 2020 | $1,848,000 | -59.2% | 50,106 | -65.7% | 0.01% | -58.6% |
| Q2 2020 | $4,531,000 | +12.1% | 146,256 | -0.1% | 0.03% | 0.0% |
| Q1 2020 | $4,043,000 | -5.6% | 146,428 | 0.0% | 0.03% | +52.6% |
| Q4 2019 | $4,283,000 | +54.7% | 146,428 | +1.1% | 0.02% | +46.2% |
| Q3 2019 | $2,768,000 | -12.9% | 144,783 | 0.0% | 0.01% | -7.1% |
| Q2 2019 | $3,177,000 | +1010.8% | 144,783 | +936.3% | 0.01% | +1300.0% |
| Q1 2019 | $286,000 | +62.5% | 13,971 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $176,000 | -80.7% | 13,971 | -86.9% | 0.00% | -75.0% |
| Q4 2016 | $913,000 | +1.2% | 106,558 | -2.9% | 0.00% | 0.0% |
| Q3 2016 | $902,000 | +199.7% | 109,762 | +192.9% | 0.00% | +300.0% |
| Q2 2016 | $301,000 | +71.0% | 37,475 | +43.6% | 0.00% | 0.0% |
| Q1 2016 | $176,000 | -88.7% | 26,102 | -86.8% | 0.00% | -87.5% |
| Q4 2015 | $1,551,000 | +64.6% | 197,049 | +19.9% | 0.01% | +60.0% |
| Q3 2015 | $942,000 | +5.3% | 164,344 | -0.7% | 0.01% | +25.0% |
| Q2 2015 | $895,000 | +32.6% | 165,438 | +14.5% | 0.00% | +33.3% |
| Q1 2015 | $675,000 | +492.1% | 144,495 | +426.8% | 0.00% | +200.0% |
| Q4 2014 | $114,000 | -20.3% | 27,429 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $143,000 | -13.3% | 27,429 | -44.6% | 0.00% | 0.0% |
| Q2 2014 | $165,000 | +36.4% | 49,516 | +42.2% | 0.00% | 0.0% |
| Q1 2014 | $121,000 | +49.4% | 34,817 | +56.4% | 0.00% | – |
| Q4 2013 | $81,000 | -28.9% | 22,262 | -41.5% | 0.00% | -100.0% |
| Q3 2013 | $114,000 | – | 38,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |